CVS Health Corporation
CVSNYSEHealthcareHealthcare Plans
As of Oct 23, 2026 close
- Market cap
- $120.30B
- P/E (TTM)
- 24.60
- Forward P/E
- 22.88
- Dividend yield
- 3.52%
- 52-week range
- $69.51$110.68
- Volume (live)
- -
- Avg. volume (3M)
- 9.00M
CVS Health (CVS) Stock Price & Financial Analysis
CVS Health Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $93.22 - $94.40 |
|---|---|
| 52-Week High | $110.68 |
| 52-Week Low | $69.51 |
| Open | $94.00 |
| Volume (last close) | 4.60M |
| Average Volume (3M) | 9.00M |
| Revenue (TTM) | 414.45B |
|---|---|
| Net Income (TTM) | 4.89B |
| Free Cash Flow (TTM) | 11.76B |
| EPS (TTM) | $3.83 |
| Profit Margin | 1.18% |
| Operating Margin | 2.00% |
| Return on Equity (ROE) | 6.14% |
| Debt to Equity | 0.77 |
| Annual Dividend | $2.66 |
|---|---|
| Dividend Yield | 3.52% |
| Payout Ratio | 86.90% |
| Last Dividend Ex-Date | Oct 22, 2026 |
| Market Cap | 120.30B |
|---|---|
| Shares Outstanding | 1.29B |
| P/E Ratio (TTM) | 24.60 |
| Forward P/E | 22.88 |
| Price to Sales (P/S) | 0.29 |
| Price to Book (P/B) | 1.51 |
| EV/EBITDA | 9.32 |
| 50-Day MA | $91.65 |
|---|---|
| 200-Day MA | $88.32 |
| 1-Year Change | +16.54% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
CVS Health at a Glance
As of the Oct 23, 2026 close, CVS Health (CVS) has a market capitalization of $120.30B. The stock trades at 24.6× trailing earnings, 22.9× forward earnings and 0.3× sales. Over the trailing twelve months it earned $4.89B on revenue of $414.45B (a 1.2% profit margin) and generated $11.76B of free cash flow. Revenue grew 7.4% year over year.
As of its latest reported balance sheet, it holds $11.33B in cash and securities against $61.41B of debt, a net debt position of $50.08B.
CVS Health pays a quarterly dividend totaling $2.66 per share a year, a 3.52% yield at the Oct 23, 2026 close, with a 87% payout ratio.
The share price is up 16.5% over the past year. At $93.47 (the Oct 23, 2026 close) it sits within its 52-week range of $69.51 to $110.68, above its 200-day moving average of $88.32.
Based on 23 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $114.59, 22.6% above the Oct 23, 2026 close.
Frequently Asked Questions About CVS Health
What is the current stock price for CVS?
As of the Oct 23, 2026 close, CVS stock trades at $93.47. The 52-week range is $69.51–$110.68, with a day range of $93.22–$94.40.
What is the P/E ratio for CVS?
As of the Oct 23, 2026 close, CVS Health's trailing twelve-month (TTM) P/E ratio is 24.6, meaning investors pay $24.6 for every $1 of annual earnings. The forward P/E is 22.9, reflecting analyst expectations for future earnings. CVS Health operates in the Healthcare sector.
Does CVS pay dividends?
Yes, CVS Health pays a 3.52% annual dividend yield as of the Oct 23, 2026 close ($2.66 per share a year). The trailing twelve-month payout ratio is 86.9%. The most recent ex-dividend date was October 22, 2026.
What do analysts recommend for CVS?
Based on ratings from 23 professional analysts over the last 90 days, the consensus for CVS is Buy. The average 12-month price target is $114.59, a 22.6% upside from the Oct 23, 2026 close of $93.47.
What is the market cap of CVS?
As of the Oct 23, 2026 close, CVS Health's market capitalization is $120.30B, classifying it as a large-cap company. CVS Health operates in the Healthcare sector within the Healthcare Plans industry.